These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21242408)

  • 61. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study.
    Basciani M; Di Rienzo F; Bizzarrini M; Zanchi M; Copetti M; Intiso D
    Arch Dermatol Res; 2014 Jul; 306(5):497-503. PubMed ID: 24522897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N
    J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Topical local anaesthetic (tetracaine) reduces pain from botulinum toxin injections for axillary hyperhidrosis.
    O'Riordan JM; Fitzgerald E; Gowing C; O'Grady H; Feeley TM; Tierney S
    Br J Surg; 2006 Jun; 93(6):713-4. PubMed ID: 16671065
    [No Abstract]   [Full Text] [Related]  

  • 65. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox.
    Glogau RG
    Dermatol Surg; 1998 Aug; 24(8):817-9. PubMed ID: 9723044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treating childhood hyperhidrosis with botulinum toxin type A.
    Bhakta BB; Roussounnis SH
    Arch Dis Child; 2002 Jan; 86(1):68. PubMed ID: 11806899
    [No Abstract]   [Full Text] [Related]  

  • 69. Addressing recent concerns in comparative studies of botulinum toxin type A.
    de Boulle K; de Almeida AT
    J Cosmet Laser Ther; 2010 Oct; 12(5):246-8. PubMed ID: 20825255
    [No Abstract]   [Full Text] [Related]  

  • 70. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
    Vlahovic TC; Dunn SP; Blau JC; Gauthier C
    J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Introduction. Botulinum toxin].
    Beylot C; Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S53-4. PubMed ID: 19576485
    [No Abstract]   [Full Text] [Related]  

  • 74. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients.
    Marcella S; Goodman G; Cumming S; Foley P; Morgan V
    Australas J Dermatol; 2011 May; 52(2):123-6. PubMed ID: 21605096
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of palmar hyperhidrosis with botulinum neurotoxin a.
    Mannava S; Mannava KA; Nazir OF; Plate JF; Smith BP; Koman LA; Tuohy CJ
    J Hand Surg Am; 2013 Feb; 38(2):398-400. PubMed ID: 23267759
    [No Abstract]   [Full Text] [Related]  

  • 78. RimabotulinumtoxinB versus OnabotulinumtoxinA in the treatment of masseter hypertrophy: a 24-week double-blind randomized split-face study.
    Lee DH; Jin SP; Cho S; Feneran A; Youn CS; Won CH; Park GH; Kim BW; An J; Chang SE; Lee MW
    Dermatology; 2013; 226(3):227-32. PubMed ID: 23774030
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Palmar hyperhidrosis in a 13-year-old boy: treatment with botulinum toxin A.
    Vázquez-López ME; Pego-Reigosa R
    Clin Pediatr (Phila); 2005; 44(6):549-51. PubMed ID: 16015405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.